Advanced search
Publication Cover
Expert Review of Vaccines Volume 16, 2017 - Issue 4
Submit an article Journal homepage
18,441
Views
173
CrossRef citations to date
0
Altmetric
Review

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

Ray BorrowVaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, UKCorrespondence[email protected]
View further author information
,
Pedro AlarcónLaboratory Gram - Positive Coccus, Instituto de Salud Pública de Chile, Santiago, ChileView further author information
,
Josefina CarlosDepartment of Pediatrics, College of Medicine, University of the East – Ramon Magsaysay Memorial Medical Center, Quezon City, PhilippinesView further author information
,
Dominique A. CaugantDepartment of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, NorwayView further author information
,
Hannah ChristensenSchool of Social and Community Medicine, University of Bristol, Bristol, UKView further author information
,
Roberto DebbagPediatric Telemedicine Service, Malvinas Children’s Hospital, Buenos Aires, ArgentinaView further author information
,
Philippe De WalsDepartment of Social and Preventive Medicine, Laval University, Quebec City, QC, CanadaView further author information
,
Gabriela Echániz-AvilesCenter for Infectious Disease Research, Instituto Nacional de Salud Pública, Cuernavaca, MexicoView further author information
,
Jamie FindlowVaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, UKView further author information
,
Chris HeadMeningitis Research Foundation, Thornbury, UKView further author information
,
Daphne HoltGoverning Council, Confederation of Meningitis Organisations, Head Office, Bristol, UKView further author information
,
Hajime KamiyaInfectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, JapanView further author information
,
Samir K SahaChild Health Research Foundation, Department of Microbiology, Dhaka Shishu Hospital, Dhaka, BangladeshView further author information
,
Sergey SidorenkoInfectious Disease Surveillance Center, Scientific Research Institute of Children’s Infections, St Petersburg, RussiaView further author information
,
Muhamed-Kheir TahaDepartment of Infection & Epidemiology, Institut Pasteur, Paris, FranceView further author information
,
Caroline TrotterDepartment of Veterinary Medicine, University of Cambridge, Cambridge, UKView further author information
,
Julio A. Vázquez MorenoMeningococcal Reference Laboratory, Institute of Health Carlos III, Madrid, SpainView further author information
,
Anne von GottbergCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Johannesburg, South AfricaView further author information
&
Marco A. P. SáfadiDepartment of Pediatrics, FCM da Santa Casa de São Paulo, São Paulo, BrazilView further author information
 show all
Pages 313-328 | Received 09 Aug 2016, Accepted 04 Nov 2016, Published online: 22 Nov 2016

Citations (173)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (35)

Gary S. Marshall, Victoria Abbing-Karahagopian, Helen S. Marshall, Silvia Cenci, James H. Conway, Emilia Occhipinti, Rafik Bekkat-Berkani, Angelika Banzhoff & Woo-Yun Sohn. (2023) A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB). Expert Review of Vaccines 22:1, pages 530-544.
Read now
Isabella Ballalai, Rob Dawson, Michael Horn, Vinny Smith, Rafik Bekkat-Berkani, Lamine Soumahoro & Nevena Vicic. (2023) Understanding barriers to vaccination against invasive meningococcal disease: a survey of the knowledge gap and potential solutions. Expert Review of Vaccines 22:1, pages 457-467.
Read now
Salah Al Awaidy, Onur Ozudogru & Selim Badur. (2023) Meningococcal disease within the Gulf Cooperation Council Countries. Human Vaccines & Immunotherapeutics 19:1.
Read now
Gary S. Marshall, Stephen I. Pelton, Corwin A. Robertson & Philipp Oster. (2022) Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age. Human Vaccines & Immunotherapeutics 18:6.
Read now
Amanda Izeli Portilho, Victor Araujo Correa, Cinthya dos Santos Cirqueira & Elizabeth De Gaspari. (2022) Intranasal and Intramuscular Immunization with Outer Membrane Vesicles from Serogroup C Meningococci Induced Functional Antibodies and Immunologic Memory. Immunological Investigations 51:7, pages 2066-2085.
Read now
Joanna Whisnant, Jacqueline Martin-Kerry, Lydia Flett & Peter Knapp. (2022) Predictors of meningococcal vaccine uptake in university and college students: a systematic review and meta-analysis. Journal of American College Health 70:6, pages 1738-1753.
Read now
Pasquale Stefanizzi, Francesco Paolo Bianchi, Giuseppe Spinelli, Fabio Amoruso, Domenica Ancona, Paolo Stella & Silvio Tafuri. (2022) Postmarketing surveillance of adverse events following meningococcal B vaccination: data from Apulia Region, 2014–19. Human Vaccines & Immunotherapeutics 18:1, pages 1-6.
Read now
Hassen Mohammed, Mark McMillan & Helen S. Marshall. (2022) Social and behavioral predictors of two-doses 4CMenB vaccine series among adolescents enrolled in a cluster randomized controlled trial in Australia. Human Vaccines & Immunotherapeutics 18:1.
Read now
Franco M. Piazza, Miia Virta, Marita Paassilta, Benita Ukkonen, Anitta Ahonen, Alejandra Esteves-Jaramillo, Aino Forsten, Ilkka Seppa, Jian Ding, David Neveu, Emilia Jordanov & Mandeep S. Dhingra. (2022) Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study. Human Vaccines & Immunotherapeutics 18:1, pages 1-10.
Read now
Mark McMillan, Helen S Marshall & Peter Richmond. (2022) 4CMenB vaccine and its role in preventing transmission and inducing herd immunity. Expert Review of Vaccines 21:1, pages 103-114.
Read now
María Gabriela Graña, Gabriel Cavada, Marjorie Vasquez, Jing Shen, Johan Maervoet, Johan Klint & Jorge A. Gómez. (2021) Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile. Human Vaccines & Immunotherapeutics 17:12, pages 5603-5613.
Read now
Federico Martinón-Torres, Isabelle Bertrand-Gerentes & Philipp Oster. (2021) A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT. Expert Review of Vaccines 20:9, pages 1123-1146.
Read now
Anand P Dubey, Rashna Dass Hazarika, Veronique Abitbol, Shafi Kolhapure & Someya Agrawal. (2021) Mass gatherings: a review of the scope for meningococcal vaccination in the Indian context. Human Vaccines & Immunotherapeutics 17:7, pages 2216-2224.
Read now
Marco Aurelio P. Safadi, Federico Martinón-Torres, Lidia Serra, Cynthia Burman & Jessica Presa. (2021) Translating meningococcal serogroup B vaccines for healthcare professionals. Expert Review of Vaccines 20:4, pages 401-414.
Read now
Priya Pereira, Bernd Benninghoff & Leentje Moerman. (2020) Systematic literature review on the safety and immunogenicity of rotavirus vaccines when co-administered with meningococcal vaccines. Human Vaccines & Immunotherapeutics 16:11, pages 2861-2872.
Read now
Luciana Andrea Digieri Chicuto, Camile de Moraes, José Cássio de Moraes & Marco Aurélio P. Sáfadi. (2020) A critical analysis of serogroup B meningococcal disease burden in Brazil (2001–2015): implications for public health decisions. Human Vaccines & Immunotherapeutics 16:8, pages 1945-1950.
Read now
Weichang Luo, Peter D. Arkwright & Ray Borrow. (2020) Antibody persistence following meningococcal ACWY conjugate vaccine licensed in the European Union by age group and vaccine. Expert Review of Vaccines 19:8, pages 745-754.
Read now
Beatriz Quiambao, Paula Peyrani, Ping Li, Mark W. Cutler, Marie Van Der Wielen, John L. Perez & Chris Webber. (2020) Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine. Human Vaccines & Immunotherapeutics 16:6, pages 1272-1279.
Read now
Timo Vesikari, Ray Borrow, Aino Forsten, Helen Findlow, Mandeep S. Dhingra & Emilia Jordanov. (2020) Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study. Human Vaccines & Immunotherapeutics 16:6, pages 1306-1312.
Read now
Judith Kirstein, Miriam Pina, Judy Pan, Emilia Jordanov & Mandeep S. Dhingra. (2020) Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study. Human Vaccines & Immunotherapeutics 16:6, pages 1299-1305.
Read now
Germán Áñez, James Hedrick, Michael W. Simon, Shane Christensen, Robert Jeanfreau, Eddy Yau, Judy Pan, Emilia Jordanov & Mandeep S. Dhingra. (2020) Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study. Human Vaccines & Immunotherapeutics 16:6, pages 1292-1298.
Read now
Byung Wook Yoo, Hye Lim Jung, Yoon Seob Byeon, Dong Ki Han, Nak Yeong Jeong, Carlo Curina, Luca Moraschini, Sung Jin Kim, Chiranjiwi Bhusal, Michele Pellegrini & Yan Miao. (2020) Results from a large post-marketing safety surveillance study in the Republic of Korea with a quadrivalent meningococcal CRM-conjugate vaccine in individuals aged 2 months–55 years. Human Vaccines & Immunotherapeutics 16:6, pages 1260-1267.
Read now
Jialei Hu, Hongguang Li, Kai Chu, Qi Liang, Jingxin Li, Li Luo, Yuemei Hu, Fanyue Meng & Fengcai Zhu. (2019) Immunogenicity and safety of a meningococcal serogroups A and C tetanus toxoid conjugate vaccine (MenAC-TT): two immune schedules in toddles aged 12–23 months in China. Human Vaccines & Immunotherapeutics 15:12, pages 2952-2959.
Read now
Federico Martinón-Torres, Terry Nolan, Daniela Toneatto & Angelika Banzhoff. (2019) Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults. Human Vaccines & Immunotherapeutics 15:12, pages 2940-2951.
Read now
Tea Burmaz, Stefano Guicciardi, Vittorio Selle, Pier Luigi Lopalco, Vincenzo Baldo & Maria Pia Fantini. (2019) Management of meningococcal outbreaks: are we using the same language? Comparison of the public health policies between high-income countries with low incidence of meningococcal disease. Expert Review of Vaccines 18:5, pages 559-574.
Read now
Mark McMillan, Luke Walters, Turra Mark, Andrew Lawrence, Lex E. X. Leong, Thomas Sullivan, Geraint B. Rogers, Ross M. Andrews & Helen S. Marshall. (2019) B Part of It study: a longitudinal study to assess carriage of Neisseria meningitidis in first year university students in South Australia. Human Vaccines & Immunotherapeutics 15:4, pages 987-994.
Read now
Robert Booy, Angela Gentile, Michael Nissen, Jane Whelan & Véronique Abitbol. (2019) Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies. Human Vaccines & Immunotherapeutics 15:2, pages 470-480.
Read now
Rino Rappuoli, Mariagrazia Pizza, Vega Masignani & Kumaran Vadivelu. (2018) Meningococcal B vaccine (4CMenB): the journey from research to real world experience. Expert Review of Vaccines 17:12, pages 1111-1121.
Read now
Pavitra Keshavan, Michele Pellegrini, Kumaran Vadivelu-Pechai & Michael Nissen. (2018) An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine. Expert Review of Vaccines 17:10, pages 865-880.
Read now
Xavier Sáez-Llorens, Johnny Beltran-Rodriguez, Jose M. Novoa Pizarro, Ilhem Mensi, Pavitra Keshavan & Daniela Toneatto. (2018) Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults. Human Vaccines & Immunotherapeutics 14:5, pages 1161-1174.
Read now
A. W. Dretler, N. G. Rouphael & D. S. Stephens. (2018) Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development. Human Vaccines & Immunotherapeutics 14:5, pages 1146-1160.
Read now
Rouba Shaker, Danielle Fayad & Ghassan Dbaibo. (2018) Challenges and opportunities for meningococcal vaccination in the developing world. Human Vaccines & Immunotherapeutics 14:5, pages 1084-1097.
Read now
Lara Evellyn do Macedo, Viviane Matos Ferreira, Caroline Alves Feitosa, Amélia Maria Pithon Borges Nunes, Leila Carvalho Campos & Marco Aurélio Palazzi Sáfadi. (2018) Impact of meningococcal C conjugate vaccination programs with and without catch-up campaigns in adolescents: Lessons learned from Bahia, Brazil. Human Vaccines & Immunotherapeutics 14:5, pages 1131-1137.
Read now
Mustapha M. Mustapha & Lee H. Harrison. (2018) Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges. Human Vaccines & Immunotherapeutics 14:5, pages 1107-1115.
Read now
Andrew Vyse, Gillian Ellsbury & Harish Madhava. (2018) Protecting UK adolescents and adults against meningococcal serogroup B disease. Expert Review of Vaccines 17:3, pages 229-237.
Read now

Articles from other publishers (138)

M. P. Kostinov, V. V. ZverevO. A. Svitich & I. S. Mukhachev. (2023) Vaccination of Persons Subject to Call-up for Military Service. Epidemiology and Vaccinal Prevention 22:5, pages 58-62.
Crossref
Hamdy Ibrahim, Safwat Abdel Maksod, Magdy Khorshed, Ahmed Alsisi, Nasser Fouad, Hanan Rady, Alaaa Al Amir, Adel Mohamed & Mohamed Hosny. (2023) Meningococcal meningitis, a life-threatening disease with a dangerous skin rash: two case reports. The Egyptian Journal of Internal Medicine 35:1.
Crossref
George Kassianos, Osamah Barasheed, Victoria Abbing-Karahagopian, Mansour Khalaf, Serdar Ozturk, Angelika Banzhoff & Selim Badur. (2023) Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review. Infectious Diseases and Therapy 12:9, pages 2193-2219.
Crossref
Katharina Schley, Jack C. Kowalik, Shannon M. Sullivan, Andrew Vyse, Carole Czudek, Eszter Tichy & Jamie Findlow. (2023) Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK: Does the Adolescent MenACWY Programme Provide Sufficient Protection?. Vaccines 11:5, pages 940.
Crossref
Na Zhao, Supen Wang, Lan Wang, Yingying Shi, Yixin Jiang, Tzu-Jung Tseng, Shelan Liu, Ta-Chien Chan & Zhiruo Zhang. (2023) Epidemiological features and trends in the mortality rates of 10 notifiable respiratory infectious diseases in China from 2004 to 2020: Based on national surveillance. Frontiers in Public Health 11.
Crossref
Rajendra Rohokale & Zhongwu Guo. (2023) Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines. ACS Infectious Diseases 9:2, pages 178-212.
Crossref
Alexiane Baloche, Claude Dussart, Pierrick Bedouch, Florence Carrouel & Gérard Mick. (2023) Epidemiology and Clinical Burden of Meningococcal Disease in France: Scoping Review. Journal of Clinical Medicine 12:3, pages 849.
Crossref
L. S. Namazova­-Baranova, O. A. Perminova, T. A. Romanova, V. V. Romanenko, A. N. Galustyan, V. N. Gorodin, I. V. OsipovaV. Yu. Rodnikova, S. M. Kharit, Yu. V. Kovshirina, V. А. Anokhin, S. B’Chir, D. Neveu, M. Bonaparte, G. Áñez, E. Jordanov, M. S. Dhingra & A. V. Goldstein. (2023) Immunogenicity and Safety of a Quadrivalent Meningococcal Tetanus Toxoid­-Conjugate Vaccine (MenACYW­-TT) Administered Concomitantly with Pneumococcal Conjugate Vaccine in Healthy Toddlers in the Russian Federation: a Phase III Randomized Study. Epidemiology and Vaccinal Prevention 21:6, pages 65-81.
Crossref
Sandra Guedes, Hélène Bricout, Edith Langevin, Sabine Tong & Isabelle Bertrand-Gerentes. (2022) Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 – a secondary database analysis. BMC Public Health 22:1.
Crossref
George A. Syrogiannopoulos, Aspasia N. Michoula & Ioanna N. Grivea. (2022) Global Epidemiology of Vaccine-preventable Bacterial Meningitis. Pediatric Infectious Disease Journal 41:12, pages e525-e529.
Crossref
Rafik Bekkat-Berkani, Elena Fragapane, Scott Preiss, Rino Rappuoli, Woo-Yun Sohn, Lamine Soumahoro & Kumaran Vadivelu. (2022) Public health perspective of a pentavalent meningococcal vaccine combining antigens of MenACWY-CRM and 4CMenB. Journal of Infection 85:5, pages 481-491.
Crossref
Vikrant Kumar, Richard B. Pouw, Matias I. Autio, Manfred G. Sagmeister, Zai Yang Phua, Lisa Borghini, Victoria J. Wright, Clive Hoggart, Bangfen Pan, Antson Kiat Yee Tan, Alexander Binder, Mieke C. Brouwer, Ellie Pinnock, Ronald De Groot, Jan Hazelzet, Marieke Emonts, Michiel Van Der Flier, Karl Reiter, Markus M. Nöthen, Per Hoffmann, Luregn J. Schlapbach, Evangelos Bellos, Suzanne Anderson, Fatou Secka, Federico Martinón-Torres, Antonio Salas, Colin Fink, Enitan D. Carrol, Andrew J. Pollard, Lachlan J. Coin, Werner Zenz, Diana Wouters, Lay Teng Ang, Martin L. Hibberd, Michael Levin, Taco W. Kuijpers & Sonia Davila. (2022) Variation in CFHR3 determines susceptibility to meningococcal disease by controlling factor H concentrations. The American Journal of Human Genetics 109:9, pages 1680-1691.
Crossref
Victor Araujo Correa, Amanda Izeli Portilho & Elizabeth De Gaspari. (2022) Immunological Effects of Dimethyldioctadecylammonium Bromide and Saponin as Adjuvants for Outer Membrane Vesicles from Neisseria meningitidis. Diseases 10:3, pages 46.
Crossref
Giorgia Sulis, Miranda Horn, Ray Borrow & Nicole E. Basta. (2022) A comparison of national vaccination policies to prevent serogroup B meningococcal disease. Vaccine 40:26, pages 3647-3654.
Crossref
Richard Kensinger & Arun B. Arunachalam. (2022) Preclinical development of the quadrivalent meningococcal (ACYW) tetanus toxoid conjugate vaccine, MenQuadfi®. Glycoconjugate Journal 39:3, pages 381-392.
Crossref
Anna E. van Beek, Richard B. Pouw, Victoria J. Wright, Neneh Sallah, David Inwald, Clive Hoggart, Mieke C. Brouwer, Rachel Galassini, John Thomas, Leo Calvo-Bado, Colin G. Fink, Ilse Jongerius, Martin Hibberd, Diana Wouters, Michael Levin & Taco W. Kuijpers. (2022) Low Levels of Factor H Family Proteins During Meningococcal Disease Indicate Systemic Processes Rather Than Specific Depletion by Neisseria meningitidis. Frontiers in Immunology 13.
Crossref
Alexiane Baloche, Camille Jung, Michael Levy, Annie Elbez-Rubinstein, Stéphane Béchet, Ines Layouni, Geneviève Monguillot, Muhamed Kheir Taha, Robert Cohen & Corinne Levy. (2022) Long-term impact of invasive meningococcal disease in children: SEINE study protocol. PLOS ONE 17:5, pages e0268536.
Crossref
Irene Rivero-Calle, Peter Francis Raguindin, Jacobo Pardo-Seco & Federico Martinon-Torres. (2022) Risk Analysis by Age on the Burden of Meningococcal Disease in Spain. Vaccines 10:4, pages 592.
Crossref
Ottavia Prunas, Daniel M Weinberger, Duccio Medini, Michele Tizzoni & Lorenzo Argante. (2022) Evaluating the Impact of Meningococcal Vaccines With Synthetic Controls. American Journal of Epidemiology 191:4, pages 724-734.
Crossref
Helen S. Marshall, Prabha H. Andraweera, James Ward, John Kaldor, Ross Andrews, Kristine Macartney, Peter Richmond, Vicki Krause, Ann Koehler, David Whiley, Lynne Giles, Rosalind Webby, Heather D’Antoine, Jonathan Karnon, Rob Baird, Andrew Lawrence, Helen Petousis-Harris, Philippe De Wals, Belinda Greenwood-Smith, Michael Binks & Lisa Whop. (2022) An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol. Vaccines 10:2, pages 309.
Crossref
Mark McMillan, Ann P Koehler, Andrew Lawrence, Thomas R Sullivan, Jana Bednarz, Jenny M MacLennan, Martin C J Maiden, Shamez N Ladhani, Mary E Ramsay, Caroline Trotter, Ray Borrow, Adam Finn, Charlene M Kahler, Jane Whelan, Kumaran Vadivelu, Peter C Richmond & Helen S Marshall. (2022) B Part of It School Leaver Study: A Repeat Cross-Sectional Study to Assess the Impact of Increasing Coverage With Meningococcal B (4CMenB) Vaccine on Carriage of Neisseria meningitidis . The Journal of Infectious Diseases 225:4, pages 637-649.
Crossref
Mariana C. Cruz, Paulo Camargos & Cristiana M. Nascimento‐Carvalho. (2022) Impact of meningococcal C conjugate vaccine on incidence of invasive meningococcal disease in an 18‐year time series in Brazil and in distinct Brazilian regions. Tropical Medicine & International Health.
Crossref
Helen Campbell, Nick Andrews, Sydel R Parikh, Joanne White, Michael Edelstein, Xilian Bai, Jay Lucidarme, Ray Borrow, Mary E Ramsay & Shamez N Ladhani. (2022) Impact of an adolescent meningococcal ACWY immunisation programme to control a national outbreak of group W meningococcal disease in England: a national surveillance and modelling study. The Lancet Child & Adolescent Health 6:2, pages 96-105.
Crossref
Yunyi Zhang, Xuan Deng, Yan Jiang, Junyan Zhang, Li Zhan, Lingling Mei, Hangjing Lu, Pingping Yao & Hanqing He. (2022) The Epidemiology of Meningococcal Disease and Carriage, Genotypic Characteristics and Antibiotic Resistance of Neisseria meningitidis Isolates in Zhejiang Province, China, 2011–2021. Frontiers in Microbiology 12.
Crossref
Arun B. Arunachalam, Stacey Vile & Angel Rosas. (2022) A Mouse Immunogenicity Model for the Evaluation of Meningococcal Conjugate Vaccines. Frontiers in Immunology 13.
Crossref
I. S. Koroleva & M. A. Koroleva. (2022) World Experience in the Use Serogroup B Meningococcal Vaccines (literature review). Epidemiology and Vaccinal Prevention 20:6, pages 100-107.
Crossref
Marlon Macias-Mendoza, Alfredo Montes-Robledo, Cindy Arteta-Acosta, Rosa Baldiris-Avila & Wilfrido Coronell-Rodríguez. (2022) Identification of the nasopharyngeal carriage of Neisseria meningitidis by 16S rRNA Gene sequencing in asymptomatic adolescents and young adults in Cartagena, Colombia (2019–2020).. The Brazilian Journal of Infectious Diseases 26:1, pages 102330.
Crossref
Raquel Abad & Julio A. Vázquez. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity 542 558 .
Cheorl-Ho KimCheorl-Ho Kim. 2022. Glycobiology of Innate Immunology. Glycobiology of Innate Immunology 199 260 .
Laleh Sheikhi Moghaddam, Ayobami Adegbite & Pumtiwitt C. McCarthy. (2021) Investigation of bioluminescence-based assays for determination of kinetic parameters for the bifunctional Neisseria meningitidis serogroup W capsule polymerase. BMC Research Notes 14:1.
Crossref
Selim Badur, Mona A. Al Dabbagh, Atef M. Shibl, Fayssal M. Farahat, Serdar Öztürk, Debasish Saha & Mansour Khalaf. (2021) The Epidemiology of Invasive Meningococcal Disease in the Kingdom of Saudi Arabia: A Narrative Review with Updated Analysis. Infectious Diseases and Therapy 10:4, pages 2035-2049.
Crossref
R. Menezes Martins, A.R.S. Périssé, L.A.B. Camacho, M.L. Leal, M.L.S. Maia, A. Homma & E. Jessouroun. (2021) Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine. The Brazilian Journal of Infectious Diseases 25:6, pages 101652.
Crossref
Yara Ruiz García, Woo-Yun Sohn, Kate L. Seib, Muhamed-Kheir Taha, Julio A. Vázquez, Ana Paula S. de Lemos, Kumaran Vadivelu, Mariagrazia Pizza, Rino Rappuoli & Rafik Bekkat-Berkani. (2021) Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect. npj Vaccines 6:1.
Crossref
Diederik L H Koelman, Merel N van Kassel, Merijn W Bijlsma, Matthijs C Brouwer, Diederik van de Beek & Arie van der Ende. (2021) Changing Epidemiology of Bacterial Meningitis Since Introduction of Conjugate Vaccines: 3 Decades of National Meningitis Surveillance in The Netherlands. Clinical Infectious Diseases 73:5, pages e1099-e1107.
Crossref
Brenda Anna Kwambana-Adams, Adam L Cohen, Lee Hampton, Aquino Albino Nhantumbo, Robert S Heyderman, Martin Antonio, Andre Bita & Jason Mathiu Mwenda. (2021) Toward Establishing Integrated, Comprehensive, and Sustainable Meningitis Surveillance in Africa to Better Inform Vaccination Strategies. The Journal of Infectious Diseases 224:Supplement_3, pages S299-S306.
Crossref
F. Martinón-Torres, A. Banzhoff, C. Azzari, P. de Wals, R. Marlow, H. Marshall, M. Pizza, R. Rappuoli & R. Bekkat-Berkani. (2021) Recent advances in the prevention of meningococcal B disease: Real evidence from 4CMenB vaccination. Vacunas (English Edition) 22:3, pages 189-202.
Crossref
F. Martinón-Torres, A. Banzhoff, C. Azzari, P. de Wals, R. Marlow, H. Marshall, M. Pizza, R. Rappuoli & R. Bekkat-Berkani. (2021) Avances recientes en la prevención de la enfermedad meningocócica B: evidencia real de la vacunación con 4CMenB. Vacunas 22:3, pages 189-202.
Crossref
Mark McMillan, Abira Chandrakumar, Hua Lin Rachael Wang, Michelle Clarke, Thomas R Sullivan, Ross M Andrews, Mary Ramsay & Helen S Marshall. (2021) Effectiveness of Meningococcal Vaccines at Reducing Invasive Meningococcal Disease and Pharyngeal Neisseria meningitidis Carriage: A Systematic Review and Meta-analysis . Clinical Infectious Diseases 73:3, pages e609-e619.
Crossref
Jennifer L. Jones, Frances Tse, Matthew W. Carroll, Jennifer C. deBruyn, Shelly A. McNeil, Anne Pham-Huy, Cynthia H. Seow, Lisa L. Barrett, Talat Bessissow, Nicholas Carman, Gil Y. Melmed, Otto G. Vanderkooi, John K. Marshall & Eric I. Benchimol. (2021) Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 2: Inactivated Vaccines. Gastroenterology 161:2, pages 681-700.
Crossref
Brianna R. Morello, Adriana Milazzo, Helen S. Marshall & Lynne C. Giles. (2021) Lessons for and from the COVID-19 pandemic response — An appraisal of guidance for the public health management of Invasive Meningococcal Disease. Journal of Infection and Public Health 14:8, pages 1069-1074.
Crossref
Jennifer L Jones, Frances Tse, Matthew W Carroll, Jennifer C deBruyn, Shelly A McNeil, Anne Pham-Huy, Cynthia H Seow, Lisa L Barrett, Talat Bessissow, Nicholas Carman, Gil Y Melmed, Otto G Vanderkooi, John K Marshall & Eric I Benchimol. (2021) Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)—Part 2: Inactivated Vaccines. Journal of the Canadian Association of Gastroenterology 4:4, pages e72-e91.
Crossref
Elissa G. Currie & Scott D. Gray-Owen. (2021) Exploring the Ability of Meningococcal Vaccines to Elicit Mucosal Immunity: Insights from Humans and Mice. Pathogens 10:7, pages 906.
Crossref
Isabel dos Santos Souza, Jason Ziveri, Haniaa Bouzinba-Segard, Philippe Morand & Sandrine Bourdoulous. (2021) Meningococcus, this famous unknown. Comptes Rendus. Biologies 344:2, pages 127-143.
Crossref
Mark McMillan, Luke Walters, Thomas Sullivan, Lex E X Leong, Mark Turra, Andrew Lawrence, Ann P Koehler, Adam Finn, Ross M Andrews & Helen S Marshall. (2021) Impact of Meningococcal B (4CMenB) Vaccine on Pharyngeal Neisseria meningitidis Carriage Density and Persistence in Adolescents . Clinical Infectious Diseases 73:1, pages e99-e106.
Crossref
Susan Meiring, Cheryl Cohen, Linda de Gouveia, Mignon du Plessis, Karistha Ganesh, Jackie Kleynhans, Vanessa Quan, Stefano Tempia & Anne von Gottberg. (2021) Human Immunodeficiency Virus Infection Is Associated With Increased Meningococcal Carriage Acquisition Among First-year Students in 2 South African Universities. Clinical Infectious Diseases 73:1, pages e28-e38.
Crossref
Federico Martinón-Torres, Angelika Banzhoff, Chiara Azzari, Philippe De Wals, Robin Marlow, Helen Marshall, Mariagrazia Pizza, Rino Rappuoli & Rafik Bekkat-Berkani. (2021) Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination. Journal of Infection 83:1, pages 17-26.
Crossref
Snezana Delic, Vera Mijac, Ina Gajic, Dusan Kekic, Lazar Ranin, Boris Jegorovic, Davor Culic, Valentina Cirkovic, Marina Siljic, Maja Stanojevic, Metka Paragi, Milos Markovic & Natasa Opavski. (2021) A Laboratory-Based Surveillance Study of Invasive Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae Diseases in a Serbian Pediatric Population—Implications for Vaccination. Diagnostics 11:6, pages 1059.
Crossref
Abdul Rahman Bizri, Abdulhakeem Althaqafi, Nawal Kaabi, Nathir Obeidat, Nadine Al Akoury & Hammam Haridy. (2021) The Burden of Invasive Vaccine-Preventable Diseases in Adults in the Middle East and North Africa (MENA) Region. Infectious Diseases and Therapy 10:2, pages 663-685.
Crossref
Laura Willerton, Jay Lucidarme, Andrew Walker, Aiswarya Lekshmi, Stephen A. Clark, Steve J. Gray & Ray Borrow. (2021) Increase in penicillin-resistant invasive meningococcal serogroup W ST-11 complex isolates in England. Vaccine 39:19, pages 2719-2729.
Crossref
Ellie K Pilat, James M Stuart & Clare E French. (2021) Tobacco smoking and meningococcal disease in adolescents and young adults: a systematic review and meta-analysis. Journal of Infection 82:5, pages 135-144.
Crossref
H. N. Kharkhal & L. P. Titov. (2021) COMPARATIVE CHARACTERISTICS OF THE GENETIC STRUCTURE OF THE MENINGOKOCCAL POPULATION IN THE REPUBLIC OF BELARUS IN THE PREVACCINAL PERIOD. Молекулярная и прикладная генетика 30, pages 49-60.
Crossref
Noritaka Sekiya, Tomimasa Sunagawa, Hideyuki Takahashi, Hajime Kamiya, Shuji Yoshino, Makoto Ohnishi, Nobuhiko Okabe & Kiyosu Taniguchi. (2021) Serogroup B invasive meningococcal disease (IMD) outbreak at a Japanese high school dormitory: An outbreak investigation report from the first IMD outbreak in decades. Vaccine 39:15, pages 2177-2182.
Crossref
C. Flatrès, J.M. Roué, C. Picard, L. Carausu, C. Thomas, I. Pellier, F. Millot, V. Gandemer, J. Chantreuil, F. Lorton, C. Gras Le Guen & E. Launay. (2021) Investigation of primary immune deficiency after severe bacterial infection in children: A population-based study in western France. Archives de Pédiatrie.
Crossref
Muhamed-Kheir Taha, Jessica Presa & Lidia Serra. (2021) A Review of the Epidemiology of Invasive Meningococcal Disease and Vaccination Strategies in North Africa. International Journal of Infectious Diseases 104, pages 189-197.
Crossref
Alessia Biolchi, Sara Tomei, Laura Santini, Rita La Gaetana, Elena Mori, Patricia Novy, Rino Rappuoli, Rafik Bekkat-Berkani, Marzia Monica Giuliani & Mariagrazia Pizza. (2020) Four-component Meningococcal Serogroup B Vaccine Induces Antibodies With Bactericidal Activity Against Diverse Outbreak Strains in Adolescents. Pediatric Infectious Disease Journal 40:2, pages e66-e71.
Crossref
Giselle P. Silva, Wania F. Pereira-Manfro, Priscilla R. Costa, Dayane A. Costa, Bianca Ferreira, Daniela M. Barreto, Ana Cristina C. Frota, Cristina B. Hofer, Carlos M. Figueredo, Barbara Coelho, Esper G. Kallas & Lucimar G. Milagres. (2021) Association between circulating exhausted CD4+ T cells with poor meningococcal C conjugate vaccine antibody response in HIV-infected children and adolescents. Clinics 76, pages e2902.
Crossref
M. S. Dhingra, L. Namazova-Baranova, J. L. Arredondo-Garcia, K.-H. Kim, K. Limkittikul, W. Jantarabenjakul, O. Perminova, I. A. R. Kobashi, C.-W. Bae, J. Ojeda, J. Park, D. Chansinghakul, S. B'Chir, D. Neveu, M. Bonaparte & E. Jordanov. (2021) Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine administered concomitantly with other paediatric vaccines in toddlers: a phase III randomised study. Epidemiology and Infection 149.
Crossref
D. van der Vliet, T. Vesikari, B. Sandner, F. Martinón-Torres, G. Muzsay, A. Forsten, T. Adelt, C. Diaz Gonzalez, R. Simko, S. B'Chir, D. Neveu, E. Jordanov & M. S. Dhingra. (2021) Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs . a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study . Epidemiology and Infection 149.
Crossref
Altacílio Aparecido Nunes, Ariane De Jesus Lopes De Abreu, Otavio Cintra, Monica A.C.T. Cintra, Eduardo Barbosa Coelho & Eliana Nogueira Castro De Barros. (2021) Meningococcal disease epidemiology in Brazil (2005–2018) and impact of MenC vaccination. Vaccine 39:3, pages 605-616.
Crossref
Josephine Mauskopf, Catherine Masaquel & Liping Huang. (2021) Evaluating Vaccination Programs That Prevent Diseases With Potentially Catastrophic Health Outcomes: How Can We Capture the Value of Risk Reduction?. Value in Health 24:1, pages 86-90.
Crossref
Priyal Bagwe, Lotika Bajaj, Rikhav Gala, Susu M. Zughaier, Mohammad N. Uddin & Martin J. D’Souza. (2020) Meningococcal Vaccines: Challenges and Prospects. Vaccines 8:4, pages 738.
Crossref
Ravinder Mettu, Chiang-Yun Chen & Chung-Yi Wu. (2020) Synthetic carbohydrate-based vaccines: challenges and opportunities. Journal of Biomedical Science 27:1.
Crossref
Shu-Jin Fan, Hong-Kun Tan, Yu-Cheng Xu, Yuan-Zhi Chen, Tian-Ao Xie, Zhi-Yong Pan, Shi Ouyang, Qin Li, Xiao-yan Li, Zhen-Xing Li & Xu-Guang Guo. (2020) A pooled analysis of the LAMP assay for the detection of Neisseria meningitidis. BMC Infectious Diseases 20:1.
Crossref
Anna Carannante, Cecilia Fazio, Arianna Neri, Florigio Lista, Silvia Fillo, Andrea Ciammaruconi, Paola Vacca & Paola Stefanelli. (2020) Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014–2017. PLOS ONE 15:11, pages e0241793.
Crossref
Stephen A. Clark & Ray Borrow. (2020) Herd Protection against Meningococcal Disease through Vaccination. Microorganisms 8:11, pages 1675.
Crossref
Rafael Frandoloso, Somshukla Chaudhuri, Gabriela Carolina Paraboni Frandoloso, Rong-hua Yu & Anthony Bernard Schryvers. (2020) Proof of Concept for Prevention of Natural Colonization by Oral Needle-Free Administration of a Microparticle Vaccine. Frontiers in Immunology 11.
Crossref
Mariagrazia Pizza, Rafik Bekkat-Berkani & Rino Rappuoli. (2020) Vaccines against Meningococcal Diseases. Microorganisms 8:10, pages 1521.
Crossref
Sydel R. Parikh, Helen Campbell, Julie A. Bettinger, Lee H. Harrison, Helen S Marshall, Federico Martinon-Torres, Marco Aurelio Safadi, Zhujun Shao, Bingqing Zhu, Anne von Gottberg, Ray Borrow, Mary E Ramsay & Shamez N Ladhani. (2020) The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. Journal of Infection 81:4, pages 483-498.
Crossref
Sarah A. Mbaeyi, Catherine H. Bozio, Jonathan Duffy, Lorry G. Rubin, Susan Hariri, David S. Stephens & Jessica R. MacNeil. (2020) Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR. Recommendations and Reports 69:9, pages 1-41.
Crossref
Khadija Ait Mouss, Aziza Razki, Eva Hong, Bahija Zaki, Fakhreddine Maaloum, Néhémie Nzoyikorera, Houria Belabbes, Naima Elmdaghri & Khalid Zerouali. (2020) Epidemiological profile of Neisseria meningitidis in Casablanca, Morocco: 2010–2019. Access Microbiology 2:9.
Crossref
Johannes Beeslaar, Judith Absalon, Annaliesa S. Anderson, Joseph J. Eiden, Paul Balmer, Shannon L. Harris, Thomas R. Jones, Robert E. O’Neill, Jean-Louis Pregaldien, David Radley, Roger Maansson, John Ginis, Amit Srivastava & John L. Perez. (2020) MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies. Infectious Diseases and Therapy 9:3, pages 641-656.
Crossref
H.S. Marshall, A.P. Koehler, B. Wang, M. A'Houre, M. Gold, H. Quinn, N. Crawford, N. Pratt, T.R. Sullivan & K. Macartney. (2020) Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia. Vaccine 38:37, pages 5914-5922.
Crossref
Eva L. Sudbury, Siobhan O’Sullivan, David Lister, Deepa Varghese & Keshan Satharasinghe. (2020) Case Manifestations and Public Health Response for Outbreak of Meningococcal W Disease, Central Australia, 2017. Emerging Infectious Diseases 26:7, pages 1355-1363.
Crossref
Mandeep S. Dhingra, James Peterson, James Hedrick, Judy Pan, David Neveu & Emilia Jordanov. (2020) Immunogenicity, safety and inter-lot consistency of a meningococcal conjugate vaccine (MenACYW-TT) in adolescents and adults: A Phase III randomized study. Vaccine 38:33, pages 5194-5201.
Crossref
Fleur Lorton, Martin Chalumeau, Alain Martinot, Rémy Assathiany, Jean-Michel Roué, Pierre Bourgoin, Julie Chantreuil, Gérald Boussicault, Théophile Gaillot, Jean-Pascal Saulnier, Jocelyne Caillon, Corinne Levy, Robert Cohen, Christèle Gras-Le Guen & Elise Launay. (2020) Epidemiology of Community-Onset Severe Bacterial Infections in Children and Its Evolution: A Population-Based Study in France*. Pediatric Critical Care Medicine 21:6, pages e325-e332.
Crossref
Alejandra Esteves-Jaramillo, Timothy Koehler, Robert Jeanfreau, David Neveu, Emilia Jordanov & Mandeep Singh Dhingra. (2020) Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in ≥56-year-olds: A Phase III randomized study. Vaccine 38:28, pages 4405-4411.
Crossref
Elizabeth M. Batty, Tomas-Paul Cusack, Janjira Thaipadungpanit, Wanitda Watthanaworawit, Verena Carrara, Somsavanh Sihalath, Jill Hopkins, Sona Soeng, Clare Ling, Paul Turner & David A.B. Dance. (2020) The spread of chloramphenicol-resistant Neisseria meningitidis in Southeast Asia. International Journal of Infectious Diseases 95, pages 198-203.
Crossref
Lidia Serra, Jessica Presa, Hannah Christensen & Caroline Trotter. (2020) Carriage of Neisseria Meningitidis in Low and Middle Income Countries of the Americas and Asia: A Review of the Literature. Infectious Diseases and Therapy 9:2, pages 209-240.
Crossref
Arno Thibau, Alexander A. Dichter, Diana J. Vaca, Dirk Linke, Adrian Goldman & Volkhard A. J. Kempf. (2019) Immunogenicity of trimeric autotransporter adhesins and their potential as vaccine targets. Medical Microbiology and Immunology 209:3, pages 243-263.
Crossref
O. A. Perminova, V. V. Romanenko, V. Yu. Rodnikova, S. M. Kharit, Y. Thollot, V. Bosch-Castells & A. V. Goldstein. (2020) Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) in Children 9–23 Months of Age in Russian Federation: Results of Russian Part of International Study in Russia and India. Epidemiology and Vaccinal Prevention 19:2, pages 70-78.
Crossref
Ala-Eddine Deghmane, Sylvie Haeghebaert, Eva Hong, Améliane Jousset, Anne-Sophie Barret & Muhamed-Kheir Taha. (2020) Emergence of new genetic lineage, ST-9316, of Neisseria meningitidis group W in Hauts-de-France region, France 2013–2018. Journal of Infection 80:5, pages 519-526.
Crossref
Lee-Jah Chang, James Hedrick, Shane Christensen, Judy Pan, Emilia Jordanov & Mandeep S. Dhingra. (2020) A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States. Vaccine 38:19, pages 3560-3569.
Crossref
Viviane Matos Ferreira, Ítalo Eustáquio Ferreira, How-Yi Chang, Amélia Maria Pithon Borges Nunes, Nadav Topaz, Ellen Reis Pimentel, Ana Rafaela Silva Simões Moura, Guilherme Sousa Ribeiro, Caroline Alves Feitosa, Mitermayer Galvão Reis, Xin Wang & Leila Carvalho Campos. (2020) Meningococcal carriage in young adults six years after meningococcal C conjugate (MCC) vaccine catch-up campaign in Salvador, Brazil. Vaccine 38:14, pages 2995-3002.
Crossref
Dominique A. Caugant & Ola B. Brynildsrud. (2019) Neisseria meningitidis: using genomics to understand diversity, evolution and pathogenesis. Nature Reviews Microbiology 18:2, pages 84-96.
Crossref
Helen S. MarshallMark McMillan, Ann P. KoehlerAndrew LawrenceThomas R. SullivanJenny M. MacLennanMartin C.J. Maiden, Shamez N. LadhaniMary E. RamsayCaroline TrotterRay BorrowAdam FinnCharlene M. KahlerJane WhelanKumaran VadiveluPeter Richmond. (2020) Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia. New England Journal of Medicine 382:4, pages 318-327.
Crossref
Pere Godoy, Jesús Castilla, Jenaro Astray, José Tuells, Irene Barrabeig & Àngela Domínguez. (2020) La enfermedad meningocócica y las vacunas: algunas respuestas y todavía muchas preguntas. Gaceta Sanitaria 34:1, pages 1-3.
Crossref
Francisco José Álvarez García, María José Cilleruelo Ortega, Javier Álvarez Aldeán, María Garcés-Sánchez, Nuria García Sánchez, Elisa Garrote Llanos, Ángel Hernández Merino, Antonio Iofrío de Arce, Manuel Merino Moína, Abián Montesdeoca Melián, María Luisa Navarro Gómez, Jesús Ruiz-Contreras, Francisco José Álvarez García, María José Cilleruelo Ortega, Javier Álvarez Aldeán, María Garcés-Sánchez, Nuria García Sánchez, Elisa Garrote Llanos, Ángel Hernández Merino, Antonio Iofrío de Arce, Manuel Merino Moína, Abián Montesdeoca Melián, María Luisa Navarro Gómez & Jesús Ruiz-Contreras. (2020) Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2020. Anales de Pediatría 92:1, pages 52.e1-52.e10.
Crossref
Francisco José Álvarez García, María José Cilleruelo Ortega, Javier Álvarez Aldeán, María Garcés-Sánchez, Nuria García Sánchez, Elisa Garrote Llanos, Ángel Hernández Merino, Antonio Iofrío de Arce, Manuel Merino Moína, Abián Montesdeoca Melián, María Luisa Navarro Gómez, Jesús Ruiz-Contreras, Francisco José Álvarez García, María José Cilleruelo Ortega, Javier Álvarez Aldeán, María Garcés-Sánchez, Nuria García Sánchez, Elisa Garrote Llanos, Ángel Hernández Merino, Antonio Iofrío de Arce, Manuel Merino Moína, Abián Montesdeoca Melián, María Luisa Navarro Gómez & Jesús Ruiz-Contreras. (2020) IMMUNISATION SCHEDULE OF THE SPANISH ASSOCIATION OF PAEDIATRICS: 2020 RECOMMENDATIONS. Anales de Pediatría (English Edition) 92:1, pages 52.e1-52.e10.
Crossref
Helen Marshall, Mark McMillan, Bing Wang, Robert Booy, Hossein Afzali, Jim Buttery, Christopher C Blyth, Peter Richmond, David Shaw, David Gordon & Belinda Barton. (2019) AMEND study protocol: a case–control study to assess the long-term impact of invasive meningococcal disease in Australian adolescents and young adults. BMJ Open 9:12, pages e032583.
Crossref
Jason Hlozek, Neil Ravenscroft & Michelle M. Kuttel. (2019) Modeling the conformations of Neisseria meningitidis serogroup a CPS and a carba-analogue: Implications for vaccine development. Carbohydrate Research 486, pages 107838.
Crossref
Al-Mamoon Badahdah, Fatimah Alghabban, Wajd Falemban, Abdullah Albishri, Gouri Rani Banik, Tariq Alhawassi, Hatem Abuelizz, Marwan A. Bakarman, Ameneh Khatami, Robert Booy & Harunor Rashid. (2019) Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers. Tropical Medicine and Infectious Disease 4:4, pages 127.
Crossref
Alastair McAlpine & Manish Sadarangani. (2019) Meningitis vaccines in children. Current Opinion in Infectious Diseases 32:5, pages 510-516.
Crossref
Dylan Sheerin, Daniel O’Connor, Christina Dold, Elizabeth Clutterbuck, Moustafa Attar, Christine S. Rollier, Manish Sadarangani & Andrew J. Pollard. (2019) Comparative transcriptomics between species attributes reactogenicity pathways induced by the capsular group B meningococcal vaccine, 4CMenB, to the membrane-bound endotoxin of its outer membrane vesicle component. Scientific Reports 9:1.
Crossref
Mary Tipton, Wendy Daly, Shelly Senders, Stanley L. Block, Maria Lattanzi, Thembile Mzolo, Silvia Barbi, Michele Pellegrini & Pavitra Keshavan. (2019) MenACWY-CRM conjugate vaccine booster dose given 4–6 years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adults. Vaccine 37:42, pages 6171-6179.
Crossref
Philip S. Watson, Patricia L. Novy & Leonard R. Friedland. (2019) Potential benefits of using a multicomponent vaccine for prevention of serogroup B meningococcal disease. International Journal of Infectious Diseases 85, pages 22-27.
Crossref
Jéssica Vespa Presa, Maria Gabriela Abalos, Rodrigo Sini de Almeida & Alejandro Cane. (2019) Epidemiological burden of meningococcal disease in Latin America: A systematic literature review. International Journal of Infectious Diseases 85, pages 37-48.
Crossref
Susan Meiring, Cheryl Cohen, Linda de Gouveia, Mignon du Plessis, Ranmini Kularatne, Anwar Hoosen, Ruth Lekalakala, Sarona Lengana, Sharona Seetharam, Preneshni Naicker, Vanessa Quan, Gary Reubenson, Stefano Tempia, Claire von Mollendorf, Anne von Gottberg, John Black, Vanessa Pearce, Anwar Hoosen, Vicky Kleinhans, Alan Karstaedt, Caroline Maluleka, Charl Verwey, Charles Feldman, David Moore, Gary Reubenson, Khine Swe Swe Han, Jeannette Wadula, Jeremy Nel, Kathy Lindeque, Maphoshane Nchabeleng, Nazlee Samodien, Nicolette du Plessis, Norma Bosman, Ranmini Kularatne, Sharona Seetharam, Teena Thomas, Theunis Avenant, Trusha Nana, Vindana Chibabhai, Adhil Maharj, Asmeeta Burra, Fathima Naby, Halima Dawood, Jade Mogamberry, Koleka Mlisana, Lisha Sookan, Praksha Ramjathan, Prasha Mahabeer, Romola Naidoo, Sumayya Haffejee, Yacoob Coovadia, Ken Hamese, Ngoaka Sibiya, Ruth Lekalakala, Greta Hoyland, Jacob Lebudi, Pieter Jooste, Ebrahim Variava, Erna du Plessis, Andrew Whitelaw, Kessendri Reddy, Mark Nicol, Preneshni Naicker, Adrian Brink, Elizabeth Prentice, Inge Zietsman, Maria Botha, Peter Smith, Xoliswa Poswa, Chetna Govind, Keshree Pillay, Suzy Budavari, Catherine Samuel, Marthinus Senekal, Andries Dreyer, Khatija Ahmed, Louis Marcus, Warren Lowman, Angeliki Messina, Dena van den Bergh, Karin Swart, Cynthia Whitney, Keith Klugman, Ananta Nanoo, Andries Dreyer, Anne von Gottberg, Anthony Smith, Arvinda Sooka, Cecilia Miller, Charlotte Sriruttan, Cheryl Cohen, Chikwe Ihekweazu, Claire von Mollendorf, Desiree du Plessis, Erika Britz, Frans Radebe, Genevie Ntshoe, Gillian Hunt, Hlengain Mathema, Jacqueline Weyer, Jenny Rossouw, John Frean, Karen Keddy, Kerrigan McCarthy, Linda de Gouveia, Linda Erasmus, Lucille Blumberg, Marshagne Smith, Martha Makgoba, Motshabi Modise, Nazir Ismail, Nelesh Govender, Neo Legare, Nicola Page, Ntsieni Ramalwa, Nuraan Paulse, Phumeza Vazi, Olga Perovic, Penny Crowther-Gibson, Portia Mutevedzi, Riyadh Manesen, Ruth Mpembe, Sarona Lengana, Shabir Madhi, Sibongile Walaza, Sonwabo Lindani, Sunnieboy Njikho, Susan Meiring, Thejane Motladiile, Tiisetso Lebaka & Verushka Chetty. (2019) Declining Incidence of Invasive Meningococcal Disease in South Africa: 2003–2016. Clinical Infectious Diseases 69:3, pages 495-504.
Crossref
José Francisco Santos-Neto, Viviane Matos Ferreira, Caroline Alves Feitosa, Martha Silvia Martinez-Silveira & Leila Carvalho Campos. (2019) Carriage prevalence of Neisseria meningitidis in the Americas in the 21st century: a systematic review. The Brazilian Journal of Infectious Diseases 23:4, pages 254-267.
Crossref
Meagan E Peterson, You Li, André Bita, Annick Moureau, Harish Nair, Moe H Kyaw, Raquel Abad, Freddie Bailey, Isabel de la Fuente Garcia, Antoaneta Decheva, Pavla Krizova, Tanya Melillo, Anna Skoczynska & Nadezhda Vladimirova. (2019) Meningococcal serogroups and surveillance: a systematic review and survey. Journal of Global Health 9:1.
Crossref
Helen S Marshall, Mark McMillan, Ann Koehler, Andrew Lawrence, Jenny MacLennan, Martin Maiden, Mary Ramsay, Shamez N Ladhani, Caroline Trotter, Ray Borrow, Adam Finn, Thomas Sullivan, Peter Richmond, Charlene Kahler, Jane Whelan & Kumaran Vadivelu. (2019) B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of Neisseria meningitidis . BMJ Open 9:5, pages e027233.
Crossref
Meagan E Peterson, You Li, Heather Shanks, Rebecca Mile, Harish Nair & Moe H Kyaw. (2019) Serogroup-specific meningococcal carriage by age group: a systematic review and meta-analysis. BMJ Open 9:4, pages e024343.
Crossref
Carmen Cabellos, Ivan Pelegrín, Eva Benavent, Francesc Gudiol, Fe Tubau, Dolores Garcia-Somoza, Ricard Verdaguer, Javier Ariza & Pedro Fernandez Viladrich. (2019) Invasive Meningococcal Disease: What We Should Know, Before It Comes Back. Open Forum Infectious Diseases 6:3.
Crossref
Jéssica Vespa Presa, Rodrigo Sini de Almeida, Júlia Regazzini Spinardi & Alejandro Cane. (2019) Epidemiological burden of meningococcal disease in Brazil: A systematic literature review and database analysis. International Journal of Infectious Diseases 80, pages 137-146.
Crossref
Enrique Chacon-Cruz, Christopher Roberts, Rosa Maria Rivas-Landeros, Erika Zoe Lopatynsky-Reyes, Lucila Alejandra Almada-Salazar & Jorge Arturo Alvelais-Palacios. (2019) Pediatric meningitis due to Neisseria meningitidis, Streptococcus pneumoniae and Group B Streptococcus in Tijuana, Mexico: active/prospective surveillance, 2005–2018 . Therapeutic Advances in Infectious Disease 6, pages 204993611983227.
Crossref
Joseph Torresi, Sarah McGuinness, Karin Leder, Daniel O’Brien, Tilman Ruff, Mike Starr & Katherine GibneyJoseph Torresi, Sarah McGuinness, Karin Leder, Daniel O’Brien, Tilman Ruff, Mike Starr & Katherine Gibney. 2019. Manual of Travel Medicine. Manual of Travel Medicine 19 169 .
Abeer Sharyan, Cendy Gonzalez, Ophelia Ukaegbu, Kayla Powell & Pumtiwitt C. McCarthy. (2018) Determination of the binding affinities of Neisseria meningitidis serogroup W capsule polymerase with two nucleotide sugar substrates. BMC Research Notes 11:1.
Crossref
Fernanda Ayane de Oliveira Santos, Nilton Lincopan & Elizabeth De Gaspari. (2018) Evaluation of intranasal and subcutaneous route of immunization in neonatal mice using DODAB-BF as adjuvant with outer membrane vesicles of Neisseria meningitis B. Immunobiology 223:12, pages 750-760.
Crossref
Sara E. Oliver & Sarah A. Mbaeyi. (2018) A Review of Global Epidemiology and Response to Meningococcal Disease Outbreaks among Men Who Have Sex with Men, 2001–2018. Current Epidemiology Reports 5:4, pages 321-330.
Crossref
Bakul Javadekar, Apurba Ghosh, Rajeev Zachariah Kompithra, Shally Awasthi, Olga Perminova, Viktor Romanenko, Vera Rodnikova, Susanna Kharit, Yael Thollot, Valerie Bosch-Castells, Alexander Goldstein & Himanshu Dubey. (2018) Safety and Immunogenicity of Two Doses of a Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Indian and Russian Children Aged 9 to 17 Months. Indian Pediatrics 55:12, pages 1050-1055.
Crossref
Shinji Fukushima, Hitoshi Kikuchi, Mitsunobu Miyazu, Atsuo Hamada, Kazunobu Ouchi, Hiroki TakagiHanako MiharaToru SasakiHayato OkaValerie Bosch-Castells & Philipp Oster. (2018) A Safety and Immunogenicity Study of a Single Dose of a Meningococcal (Groups A, C, W, and Y) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (MEN-ACWY-D) in Healthy Japanese Participants. Japanese Journal of Infectious Diseases 71:6, pages 402-407.
Crossref
Simon Nadel & Nelly Ninis. (2018) Invasive Meningococcal Disease in the Vaccine Era. Frontiers in Pediatrics 6.
Crossref
Vitor Fernandes Silva, Daniel da Silva Guedes Junior, Ivna Alana da Silveira, Alessandra Santos Almeida, Fernando de Paiva Conte, Isabella Fernandes Delgado, Cristiane Caldeira Silva, Octavio Augusto França Presgrave & Katherine Antunes de Mattos. (2018) A Comparison of Pyrogen Detection Tests in the Quality Control of Meningococcal Conjugate Vaccines: The Applicability of the Monocyte Activation Test. Alternatives to Laboratory Animals 46:5, pages 255-272.
Crossref
Mercedes Macias Parra, Angela Gentile, Jorge Alejandro Vazquez Narvaez, Alejandro Capdevila, Angel Minguez, Monica Carrascal, Arnold Willemsen, Chiranjiwi Bhusal & Daniela Toneatto. (2018) Immunogenicity and safety of the 4CMenB and MenACWY-CRM meningococcal vaccines administered concomitantly in infants: A phase 3b, randomized controlled trial. Vaccine 36:50, pages 7609-7617.
Crossref
Lucimar Milagres, Giselle Silva, Wânia Pereira-Manfro, Ana Cristina Frota, Cristina Hofer, Bianca Ferreira, Daniela Barreto, Marcelo Figueredo, Barbara Coelho, Lucia Villela, Constantinos Petrovas & Richard Koup. (2018) Baseline Circulating Activated TFH and Tissue-Like Exhausted B Cells Negatively Correlate With Meningococcal C Conjugate Vaccine Induced Antibodies in HIV-Infected Individuals. Frontiers in Immunology 9.
Crossref
Wilbur H Chen, Kathleen M Neuzil, C Rebecca Boyce, Marcela F Pasetti, Mardi K Reymann, Lionel Martellet, Nancy Hosken, F Marc LaForce, Rajeev M Dhere, Sambhaji S Pisal, Amol Chaudhari, Prasad S Kulkarni, Ray Borrow, Helen Findlow, Valerie Brown, Megan L McDonough, Len Dally & Mark R Alderson. (2018) Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study. The Lancet Infectious Diseases 18:10, pages 1088-1096.
Crossref
Bing Wang, Renee Santoreneos, Hossein Afzali, Lynne Giles & Helen Marshall. (2018) Costs of Invasive Meningococcal Disease: A Global Systematic Review. PharmacoEconomics 36:10, pages 1201-1222.
Crossref
Brenda A. Kwambana-Adams, Rahab C. Amaza, Catherine Okoi, Murtala Rabiu, Archibald Worwui, Ebenezer Foster-Nyarko, Bernard Ebruke, Abdul K. Sesay, Madikay Senghore, Abdullahi S. Umar, Rabi Usman, Adamu Atiku, Garba Abdullahi, Yahaya Buhari, Rabiu Sani, Husaini U. Bako, Bashir Abdullahi, Alliyu I. Yarima, Badaru Sikiru, Aderinola Olaolu Moses, Michael O. Popoola, Eme Ekeng, Adebola Olayinka, Nwando Mba, Adamu Kankia, Ibrahim N. Mamadu, Ifeanyi Okudo, Mary Stephen, Olivier Ronveaux, Jason Busuttil, Jason M. Mwenda, Mohammed Abdulaziz, Sulaiman A. Gummi, Adebayo Adedeji, Andre Bita, Linda Omar, Mamoudou Harouna Djingarey, Wondimagegnehu Alemu, Umberto D’Alessandro, Chikwe Ihekweazu & Martin Antonio. (2018) Meningococcus serogroup C clonal complex ST-10217 outbreak in Zamfara State, Northern Nigeria. Scientific Reports 8:1.
Crossref
Charlene M. Kahler, K. L. Nawrocki, A. Anandan, Alice Vrielink & William M. Shafer. (2018) Structure-Function Relationships of the Neisserial EptA Enzyme Responsible for Phosphoethanolamine Decoration of Lipid A: Rationale for Drug Targeting. Frontiers in Microbiology 9.
Crossref
Ewelina Gowin & Danuta Januszkiewicz-Lewandowska. (2018) Genes and their single nucleotide polymorphism involved in innate immune response in central nervous system in bacterial meningitis: review of literature data. Inflammation Research 67:8, pages 655-661.
Crossref
Fadil A. Bidmos, Simon Nadel, Gavin R. Screaton, J. Simon Kroll & Paul R. Langford. (2018) Cross-Reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated From Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0. Frontiers in Immunology 9.
Crossref
Aziza Razki, Eva Hong, Khalid Zerouali, Houria Belabbes, Khadija Aitmouss, Aude Terrade, Bahija Zaki, Ala-Eddine Deghmane, Naima Elmdaghri & Muhamed-Kheir Taha. (2018) Molecular Characterization of Invasive Isolates of Neisseria meningitidis in Casablanca, Morocco. Journal of Clinical Microbiology 56:7.
Crossref
Jason Hlozek, Michelle M. Kuttel & Neil Ravenscroft. (2018) Conformations of Neisseria meningitidis serogroup A and X polysaccharides: The effects of chain length and O-acetylation. Carbohydrate Research 465, pages 44-51.
Crossref
Marieke van der Heiden, Mariette B. van Ravenhorst, Marjan Bogaard, Annemieke M.H. Boots, Guy A.M. Berbers & Anne-Marie Buisman. (2018) Lower antibody functionality in middle-aged adults compared to adolescents after primary meningococcal vaccination: Role of IgM. Experimental Gerontology 105, pages 101-108.
Crossref
Ewelina Gowin, Bogna Świątek-Kościelna, Ewelina Kałużna, Ewa Strauss, Jacek Wysocki, Jerzy Nowak, Michał Michalak & Danuta Januszkiewicz-Lewandowska. (2018) How many single-nucleotide polymorphisms (SNPs) must be tested in order to prove susceptibility to bacterial meningitis in children? Analysis of 11 SNPs in seven genes involved in the immune response and their effect on the susceptibility to bacterial meningitis in children. Innate Immunity 24:3, pages 163-170.
Crossref
Susanne Jacobsson, Bianca Stenmark, Sara Thulin Hedberg, Paula Mölling & Hans Fredlund. (2018) Neisseria meningitidis carriage in Swedish teenagers associated with the serogroup W outbreak at the World Scout Jamboree, Japan 2015 . APMIS 126:4, pages 337-341.
Crossref
M. Joseph John, Amrith Mathew, Sunil Bhat, Anushree Prabhakaran, Biju George & Jacob John. (2018) Post stem cell transplantation revaccination: A survey of the current practices in India. Vaccine 36:16, pages 2176-2180.
Crossref
Kate L Seib, Michael P Jennings & Christopher J Day. (2018) Characterizing the meningococcal glycointeractome: what is new?. Future Microbiology 13:3, pages 279-282.
Crossref
Olumide Ajibola, Semeeh Akinwale Omoleke & Olusola Akintoye Omisakin. (2018) Current status of cerebrospinal meningitis and impact of the 2015 meningococcal C vaccination in Kebbi, Northwest Nigeria. Vaccine 36:11, pages 1423-1428.
Crossref
Pumtiwitt C. McCarthy, Abeer Sharyan & Laleh Sheikhi Moghaddam. (2018) Meningococcal Vaccines: Current Status and Emerging Strategies. Vaccines 6:1, pages 12.
Crossref
Adriana Freitas de Almeida & Elizabeth De Gaspari. (2017) Dioctadecyldimethylammonium bromide (DODAB-BF) as a new adjuvant for maternal-fetal immunization in mice against Neisseria meningitidis: evaluation of humoral response. Pathogens and Disease 76:1.
Crossref
Miguel Delgado Rodríguez & Ángela Domínguez García. (2018) Pros y contras de la vacunación frente a la enfermedad por meningococo B. Medicina Clínica 150:3, pages 109-113.
Crossref
Miguel Delgado Rodríguez & Ángela Domínguez García. (2018) Pros and cons of vaccination against disease caused by serogroup B meningococcal disease. Medicina Clínica (English Edition) 150:3, pages 109-113.
Crossref
Jean-François Faucher & Marie-Cécile Ploy. 2018. Neuroepidemiology in Tropical Health. Neuroepidemiology in Tropical Health 247 267 .
Lauren L. Priniski & H. Steven Seifert. 2018. Molecular Mechanisms of Microbial Evolution. Molecular Mechanisms of Microbial Evolution 327 370 .
Sohita Dhillon & David Pace. (2017) Meningococcal Quadrivalent Tetanus Toxoid Conjugate Vaccine (MenACWY-TT; Nimenrix®): A Review. Drugs 77:17, pages 1881-1896.
Crossref
Tsitsi D. Mubaiwa, Lauren E. Hartley-Tassell, Evgeny A. Semchenko, Freda. E.-C. Jen, Yogitha N. Srikhanta, Christopher J. Day, Michael P. Jennings & Kate L. Seib. (2017) The glycointeractome of serogroup B Neisseria meningitidis strain MC58. Scientific Reports 7:1.
Crossref
Myron Christodoulides & John Heckels. (2017) Novel approaches to Neisseria meningitidis vaccine design. Pathogens and Disease 75:3.
Crossref
Andrew B Janowski & Jason G Newland. (2017) From the microbiome to the central nervous system, an update on the epidemiology and pathogenesis of bacterial meningitis in childhood. F1000Research 6, pages 86.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.